A Microalgae‐Probiotic‐Nanozyme Robot for Alleviating Intestinal Inflammation and Microbiota Dysbiosis
Advanced Materials · 2025-10 · 37 (42)
DOI: 10.1002/adma.202508754 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 05.08.2025. Verfasst von Jinjie Hou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory of Sir Run Run Shaw Hospital, College of Biosystems Engineering and Food Science, Zhejiang University School of Med…. Hauptthemen laut MEDLINE: Probiotics, Dysbiosis, Microalgae, Gastrointestinal Microbiome. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Inflammatory bowel disease is chronic gastrointestinal disorder characterized by persistent intestinal inflammation, which can lead to severe complications such as impaired intestinal barrier function and dysbiosis. Conventional therapies have challenges such as oxidative stress and insufficient intestinal colonization that hinder the treatment efficacy. Therapeutic strategies based on micro‐nano robotic delivery are promising to address the limitations of current treatments by enabling precise targeting, enhancing bioavailability, and improving therapeutic outcomes. Herein, an orally administered micro‐nano robot is developed utilizing Spirulina platensis as a carrier for nanozyme‐armed probiotic Lactobacillus plantarum (SP@LP@AuCe) to enhance the efficacy of oral probiotics and nanomedicine in treating intestinal diseases. SP@LP@AuCe exhibits strong fluorescence imaging capability due to its chlorophyll‐rich content, allowing for non‐invasive and real‐time monitoring following oral administration. The helical structure of Spirulina platensis facilitates entrapment in intestinal villi that enhances intestinal retention. Importantly, SP@LP@AuCe scavenges reactive oxygen species and modulates inflammatory responses, thereby alleviating intestinal inflammation, improving bacterial viability, and restoring the balance of intestinal microbiota. This strategy integrates microalgae, probiotics, and nanozymes within a micro‐nano robotic framework, presenting a promising approach to enhancing drug bioavailability and exerting potent anti‐inflammatory effects in the treatment of intestinal diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory of Sir Run Run Shaw Hospital, College of Biosystems Engineering and Food Science, Zhejiang University School of Medicine, Hangzhou, 310058, China.
- Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, 310016, China.
ORCID-Profile: Yunlei Xianyu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Hou, J., Zhao, M., Zou, A., Zhu, X., Fu, R., & Xianyu, Y. (2025). A Microalgae‐Probiotic‐Nanozyme Robot for Alleviating Intestinal Inflammation and Microbiota Dysbiosis. Advanced Materials, 37(42). https://doi.org/10.1002/adma.202508754
Vancouver
Hou J, Zhao M, Zou A, Zhu X, Fu R, Xianyu Y. A Microalgae‐Probiotic‐Nanozyme Robot for Alleviating Intestinal Inflammation and Microbiota Dysbiosis. Advanced Materials. 2025;37(42). doi:10.1002/adma.202508754
BibTeX
@article{Hou2025,
author = {Hou, Jinjie and Zhao, Mengliu and Zou, Anlai and Zhu, Xiaoxue and Fu, Ruijie and Xianyu, Yunlei},
title = {A Microalgae‐Probiotic‐Nanozyme Robot for Alleviating Intestinal Inflammation and Microbiota Dysbiosis},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {42},
doi = {10.1002/adma.202508754}
}
EUVIMED